Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-31

FDA Approved: BETASERON — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Bayer's supplemental application for Betaseron (interferon beta-1b), updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaseron (Interferon beta-1b)

Snippet

SUPPL AP for BETASERON (INTERFERON BETA-1B)